Hologic Increases Bets In Lab Space With $3.7 Bil. Gen-Probe Purchase
This article was originally published in The Gray Sheet
Lab diagnostic products will actually account for a larger portion of Hologic’s business post-acquisition than the firm’s core mammography, ultrasound and magnetic resonance imaging offerings.
You may also be interested in...
Hologic's partner in the blood-screening business, Grifols SA, will buy-out Hologic's share for $1.85bn. Grifols already owns all the customer-facing parts of the business; it will now take on research, development and manufacture of assays and instruments based on nucleic acid testing for transfusion and transplantation screening.
Ortho Clinical Diagnostics names new board members. Thoratec appoints president, International. Pentax Medical taps new CMO, COO. Vygon Group appoints VP of research & development.
New appointments at Hologic, Glooko and Conceptus.